news 1 month ago

Diabetes Medicine Pulled Over Carcinogen Concerns

Newser — Bob Cronin

The Food and Drug Administration has posted the voluntary recall of another metformin—the ninth brand pulled since May. Riomet ER, a Type 2 diabetes medicine marketed by Sun Pharmaceutical, was found in tests to contain too much N-nitrosodimethylamine, a carcinogen, the Miami Herald reports.

The recall applies to Lot AB06381: 500mg tablets of metformin hydrochloride labeled for extended-release oral suspension, with an expiration date of October 2021. The FDA posts a roundup of its NDMA announcements here.

(NDMA also was a concern when retail chains dropped Zantac last year.)

More From Newser

This article originally appeared on Newser: Diabetes Medicine Pulled Over Carcinogen Concerns